CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model

Liver Transplantation

Volumn 21, Issue 4, 2015, Pages 468-477

  Xiao, Zhen Yu ^a   Banan, Babak ^a   Jia, Jianluo ^a   Manning, Pamela T ^b   Hiebsch, Ronald R ^b   Gunasekaran, Muthukumar ^a   Upadhya, Gundumi A ^a   Frazier, William A ^a   Mohanakumar, Thalachallour ^a   Lin, Yiing ^a   Chapman, William C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MO 63141   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; CASPASE 3; CD47 ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD47; NITRIC OXIDE; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; BIOLOGICAL MARKER; CD47 PROTEIN, RAT;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; INFLAMMATION; LIVER CELL DAMAGE; LIVER TRANSPLANTATION; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURVIVAL; ADVERSE EFFECTS; ANIMAL; APOPTOSIS; BLOOD; CELL PROTECTION; COLD ISCHEMIA; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; LEWIS RAT; LIVER; METABOLISM; NECROSIS; PATHOLOGY; SIGNAL TRANSDUCTION; SURGERY; TIME FACTOR; VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD47; APOPTOSIS; BIOMARKERS; COLD ISCHEMIA; CYTOPROTECTION; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; LIVER; LIVER TRANSPLANTATION; MALE; NECROSIS; OXIDATIVE STRESS; RATS, INBRED LEW; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84925954411     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24059     Document Type: Article

References (41)

1. Adam R, Hoti E,. Liver transplantation: the current situation. Semin Liver Dis 2009; 29: 3-18.
2. Cillo U, Vitale A, Bassanello M, Boccagni P, Brolese A, Zanus G, et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004; 239: 150-159.
3. Gehrau RC, Mas VR, Dumur CI, Ladie DE, Suh JL, Luebbert S, Maluf DG,. Regulation of molecular pathways in ischemia-reperfusion injury after liver transplantation. Transplantation 2013; 96: 926-934.
4. Teoh NC, Farrell GC,. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891-902.
5. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ,. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000; 32: 169-173.
6. Lichtman SN, Lemasters JJ,. Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Semin Liver Dis 1999; 19: 171-187.
7. Porte RJ,. Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights. Semin Thromb Hemost 1993; 19: 191-196.
8. Fondevila C, Busuttil RW, Kupiec-Weglinski JW,. Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 2003; 74: 86-93.
9. Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM,. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl 2005; 11: 1031-1047.
10. Busuttil RW, Tanaka K,. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651-663.
11. Isenberg JS, Annis DS, Pendrak ML, Ptaszynska M, Frazier WA, Mosher DF, Roberts DD,. Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses. J Biol Chem 2009; 284: 1116-1125.
12. Chung J, Wang XQ, Lindberg FP, Frazier WA,. Thrombospondin-1 acts via IAP/CD47 to synergize with collagen in alpha2beta1-mediated platelet activation. Blood 1999; 94: 642-648.
13. Yao M, Roberts DD, Isenberg JS,. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP. Pharmacol Res 2011; 63: 13-22.
14. Isenberg JS, Hyodo F, Matsumoto K, Romeo MJ, Abu-Asab M, Tsokos M, Kuppusamy P, Wink DA, Krishna MC, Roberts DD., Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood 2007; 109: 1945-1952.
15. Isenberg JS, Romeo MJ, Yu C, Yu CK, Nghiem K, Monsale J, et al. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood 2008; 111: 613-623.
16. Bauer PM, Bauer EM, Rogers NM, Yao M, Feijoo-Cuaresma M, Pilewski JM, et al. Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1. Cardiovasc Res 2012; 93: 682-693.
17. Aguilar-Melero P, Luque A, Machuca MM, Pérez de Obanos MP, Navarrete R, Rodríguez-García IC, et al. Cardiotrophin-1 reduces ischemia/reperfusion injury during liver transplant. J Surg Res 2013; 181: e83-e91.
18. Kamada N, Calne RY,. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 47-50.
19. Kamada N, Calne RY,. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983; 93 (pt 1): 64-69.
20. Neil DA, Hubscher SG,. Are parenchymal changes in early post-transplant biopsies related to preservation-reperfusion injury or rejection? Transplantation 2001; 71: 1566-1572.
21. Shi YX, Chen Y, Zhu YZ, Huang GY, Moore PK, Huang SH, et al. Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2007; 293: H2093-H2100.
22. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vásquez-Vivar J, Kalyanaraman B,. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 2003; 34: 1359-1368.
23. Tarpey MM, Wink DA, Grisham MB,. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 2004; 286: R431-R444.
24. Rogers NM, Yao M, Novelli EM, Thomson AW, Roberts DD, Isenberg JS,. Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management. Am J Physiol Renal Physiol 2012; 303: 1117-1125.
25. Ignarro LJ,. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65: 1-21.
26. Murad F,. Cyclic GMP: synthesis, metabolism, and function. Introduction and some historical comments. Adv Pharmacol 1994; 26: 1-5.
27. Moncada S, Higgs A,. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
28. Higuchi H, Granger DN, Saito H, Kurose I,. Assay of antioxidant and antiinflammatory activity of nitric oxide in vivo. Methods Enzymol 1999; 301: 424-436.
29. Topp SG, Zhang F, Chatterjee T, Lineaweaver WC,. Role of nitric oxide in surgical flap survival. J Am Coll Surg 2005; 201: 628-639.
30. Rogers NM, Thomson AW, Isenberg JS,. Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury. J Am Soc Nephrol 2012; 23: 1538-1550.
31. Isenberg JS, Maxhimer JB, Powers P, Tsokos M, Frazier WA, Roberts DD,. Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling. Surgery 2008; 144: 752-761.
32. Hon WM, Lee KH, Khoo HE,. Nitric oxide in liver diseases: friend, foe, or just passerby. Ann N Y Acad Sci 2002; 962: 275-295.
33. Takamatsu Y, Shimada K, Yamaguchi K, Kuroki S, Chijiiwa K, Tanaka M,. Inhibition of inducible nitric oxide synthase prevents hepatic, but not pulmonary, injury following ischemia-reperfusion of rat liver. Dig Dis Sci 2006; 51: 571-579.
34. Lin Y, Manning PT, Jia J, Gaut JP, Xiao Z, Capoccia BJ, et al. CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model. Transplantation 2014; 98: 394-401.
35. Kato A, Gabay C, Okaya T, Lentsch AB,. Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion. Am J Pathol 2002; 161: 1797-1803.
36. Li CJ, Li RW, Kahl S, Elsasser TH,. Alpha-tocopherol alters transcription activities that modulates tumor necrosis factor alpha (TNF-α) induced inflammatory response in bovine cells. Gene Regul Syst Bio 2012; 6: 1-14.
37. Berthiaume F, Barbe L, Mokuno Y, MacDonald AD, Jindal R, Yarmush ML,. Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury. J Surg Res 2009; 152: 54-60.
38. Ben Mosbah I, Rosellõ-Catafau J, Alfany-Fernandez I, Rimola A, Parellada PP, Mitjavila MT, et al. Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation. Liver Transpl 2010; 16: 163-171.
39. Sun CK, Zhang XY, Zimmermann A, Davis G, Wheatley AM,. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplantation 2001; 72: 1625-1631.
40. Selzner M, Rüdiger HA, Sindram D, Madden J, Clavien PA,. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000; 32: 1280-1288.
41. Connor HD, Gao W, Nukina S, Lemasters JJ, Mason RP, Thurman RG,. Evidence that free radicals are involved in graft failure following orthotopic liver transplantation in the rat-an electron paramagnetic resonance spin trapping study. Transplantation 1992; 54: 199-204.